作者

Dr. Stefanie Greifeneder

合伙人

Read More
作者

Dr. Stefanie Greifeneder

合伙人

Read More

2024年1月30日 | 31:57 mins.

Webinar Series

Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1

Early stage IP strategy pays off – Our experts Dr. Anja Lunze, LL.M. & Tobias Baus explained the pros and cons of IP protection, how to build a custom IP strategy with a matching IP portfolio, and why early patent protection is essential for biotech & pharma start-ups.

Life science technologies will require a substantial amount of (external) financing to be successful. Our leading VC experts will help you navigate the funding process and avoid unnecessary pitfalls in negotiations with investors.

 

Download our presentation: Early Stage IP Protection

Coffee Break Life Sciences Start-ups

Sign up for our upcoming events.

To overview page
To overview page
Call To Action Arrow Image

Would you like to receive future invitations to our webinar series?

Then sign up for our mailing list.
Then sign up for our mailing list.
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

2024年4月18日
In-depth analysis

作者 Dr. Stefanie Greifeneder 以及 Irina Rebin

点击此处了解更多
商业和消费者合同

Medical devices & the EU draft regulation on AI – new challenges for my business?

2023年11月27日
In-depth analysis

作者

点击此处了解更多

相关活动